Effects of adding alendronate to ongoing hormone therapy on bone mineral density in postmenopausal Korean women

The relationship between the chemistry and biological activity of the bisphosphonates

(2011) Frank H. Ebetino et al.   BONE

Efficacy of risedronate with cholecalciferol on 25-hydroxyvitamin D level and bone turnover in Korean patients with osteoporosis

(2011) Ho-Yeon Chung et al.   CLINICAL ENDOCRINOLOGY

Osteoporosis: now and the future

(2011) Tilman D Rachner et al.   LANCET

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis

(2010) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis

(2010) Joel S. Finkelstein et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Update on Estrogens and the Skeleton

(2010) Sundeep Khosla   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bone turnover markers: understanding their value in clinical trials and clinical practice

(2009) R. Civitelli et al.   OSTEOPOROSIS INTERNATIONAL

Selective Modification of Bone Quality by PTH, Pamidronate, or Raloxifene

(2008) Tara C Brennan et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Effects of Tibolone in Older Postmenopausal Women

(2008) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE